Article Text

Download PDFPDF
Fetal Medicine Posters
Intrauterine fetal transfusion for red-cell alloimmunisation: a single-centre study over 15 years
  1. CA Walsh,
  2. N Russell,
  3. S Carroll,
  4. R Mahony,
  5. S Higgins,
  6. FM McAuliffe,
  7. P McParland
  1. Department of Fetal Medicine, National Maternity Hospital, Dublin, Ireland


Objective To examine perinatal outcomes following intrauterine fetal transfusion (IUT), in a single tertiary fetal medicine unit over a 15-year period.

Study design A retrospective analysis of women undergoing IUT in the National Maternity Hospital, Dublin from 1996-2010. Eligible cases were identified from a prospectively collated transfusion register. Cases of alloimmune thrombocytopenia, non-immune hydrops or parvovirus infection were excluded. The cord insertion was the preferred site, with the intra-hepatic vein and free cord reserved for inaccessible cases. All procedures were performed by 2 specialists in fetal medicine. Post-transfusion, women were admitted overnight, with biophysical profile and Doppler indices performed prior to discharge.

Results Between 1996 and 2010, 262 IUTs were performed in our unit, of which 244 (93%) were undertaken for red cell alloimmunisation, involving 97 pregnancies. The majority of women (84%) had anti-D antibodies, with a smaller incidence of anti-Kell (12%), anti-c (3%) and anti-E (1%) antibodies. Affected women underwent a median of 3 (IQR 2-4) procedures. In total, there were 3 intrauterine fetal deaths and 4 early neonatal deaths, for a perinatal mortality rate of 7%. The procedure-related loss rate was 1.2% (3/244). Two women had in utero fetal demise within 48 hours of the IUT, at 25 weeks and 29 weeks respectively. The third loss was from a cord haematoma at 32 weeks, with early neonatal demise.

Conclusion Intrauterine fetal transfusion is a safe procedure, associated with a low (1%) rate of procedure-related fetal loss, when performed by experienced practitioners in a national referral centre.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.